Brown C.A.; Karimi M.K.; Tian L.; Flores H.; Su Y.; Tabbal S.D.; Loftin S.K.; Moerlein S.M.; Perlmutter J.S.
(HOBOKEN111 RIVER ST, HOBOKEN 07030-5774, NJ USA, 2013)
Objective: Development of an effective therapy to slow the inexorable progression of Parkinson disease requires a reliable, objective measurement of disease severity. In the present study, we compare presynaptic positron ...